Bioinspired silk fibroin nano-delivery systems protect against 5-FU induced gastrointestinal mucositis in a mouse model and display antitumor effects on HT-29 colorectal cancer cells in vitro.

Colorectal cancer (CRC), is the second cause of cancer-related deaths worldwide is one of the most prevalent types of cancers. Conventional treatment continues to rely on surgery, chemotherapy, and radiotherapy, but for advanced cases, adjuvant chemotherapy remains the main approach for improving surgical outcomes and lower the disease recurrence probability. Chemotherapy-induced gastrointestinal (GI) toxicity is the main dose-limiting factor for many chemotherapeutic regimens, including 5-FU, and one of the biggest oncological challenges. Up to 40% of the patients receiving 5-FU get mucositis, 10-15% of which develop severe symptoms. In this context, our study aimed to develop a bioinspired nanosized drug delivery system as a strategy to reduce 5-FU associated side effects, such as GI mucositis. To this end, SF-based nanoparticles were prepared and characterized in terms of size and morphology, as well as in terms of in vitro antitumoral activity on a biomimetic colorectal cancer model by investigation of apoptosis, DNA fragmentation, and release of reactive oxygen species. Additionally, the capacity of the SF-based nanocarriers to offer intestinal protection against 5-FU-induced GI mucositis was evaluated in vivo using a mouse model that mimics the chemotherapy-associated gut mucositis occurring in colorectal cancer. Our studies show that silk fibroin nanoparticles efficiently deliver 5-FU to tumor cells in vitro while protecting against drug-induced GI mucositis in a mouse model.

Mechanisms of the charge transfer in IrQ(ppy)2-5Cl dual-emitter compound.

The synthesis of IrQ(ppy)2-5Cl has the advantage of a dual phosphorescence (green and red) which comes from the two ligands, phenylpyridine and quinoline. Their spectroscopic properties evidences the absorption range between 350 nm to 700 nm which is composed from the singlet and triplet states, as a result of hybridizations between Ir and the two ligands, the first one being at 625 nm. The first low energy state comes from the quinoline ligand and is responsible for the red phosphorescence at 660 nm, as results from the Density Functional Theory (DFT) analysis. The hybridization between Ir 5d orbitals and pi ligand orbitals shows strong metallic character with phenylpyridine orbitals (66% and 43%) and weak metallic character with quinoline ligand (16.8%). This fact suggests weak phosphorescence intensity in the emission spectra. Population analysis of each metallic orbital shows a small charge delocalization on the quinoline ligand for the first molecular orbital and a strong delocalization on the phenylpyridine ligands. Solvation effects induce a tuning process for the phosphorescence by changing of the matrix of the organometallic compounds which can be adjusted by the strength of intermolecular dipole-dipole interactions, using a doped guest-host molecular organic thin film system.